Health
Weight-loss drug Wegovy can be marketed for heart benefits after FDA label update - CNN
The US Food and Drug Administration approved drugmaker Novo Nordisk’s application to add cardiovascular benefits to the medicine’s label, making it the first weight-loss drug to also be cleared to reduce the risk of heart attack, stroke or heart-rela
By: CNN
- Mar 10 2024
- 0
- 0 Views
Wegovys not just for weight loss anymore.
The US Food and Drug Administration on Friday approved drugmaker Novo Nordisks application to add cardiovascular benefits to the medicines label, making it … [+3592 chars]